Financials
- Market Capitalization 599.83 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-13.36
Relación precio/flujo de caja
2.51
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2368 | CSTL Castle Biosciences, Inc. - Common stock | 33.64 USD | -2.27% | -6.09% | +4.15% | +36.66% | 1.03 B USD | ||
| 2374 | OPK Opko Health, Inc. - Common Stock | 1.38 USD | 0.00% | -11.54% | -13.21% | -9.80% | 1.03 B USD | ||
| 2798 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.75 USD | -2.09% | -10.50% | -29.25% | +96.34% | 552.00 M USD | ||
| 2989 | MYGN Myriad Genetics, Inc. - Common Stock | 4.29 USD | -0.46% | -4.88% | +25.44% | -48.13% | 410.34 M USD |